API Connect 2026
Concludes with Strong Industry Engagement
The inaugural edition of API Connect 2026, held on 22 January 2026 at The Belvedere Golf & Country Club, Ahmedabad, brought together senior leaders from India’s pharmaceutical ingredients ecosystem for a day of focused discussion and industry reflection.
The conference marked a shift in how sectoral forums are being approached moving away from surface-level exchanges toward conversations grounded in execution, accountability, and long-term collaboration.
Against the backdrop of evolving global pharmaceutical supply chains and increasing regulatory scrutiny, the discussions reflected a shared understanding that the future of APIs will be shaped not only by scale, but by reliability, quality systems, and decision-making maturity across organisations.
Conversations Anchored in Practice
What distinguished API Connect was its emphasis on real operational experience. Panel discussions centred on inspection readiness, data integrity, quality culture, talent development, and the growing expectation that API partners contribute to outcomes beyond supply continuity.
Moderated by Shirish G. Belapure, Senior Technical Advisor at the Indian Pharmaceutical Alliance, the sessions drew insights from leaders across manufacturing, regulatory affairs, quality, and operations. Rather than offering prescriptive solutions, the dialogue focused on how organisations are adapting internally through systems, people, and disciplined execution to meet sustained global expectations.
A recurring theme was the industry’s willingness to reflect on execution gaps and organisational culture. Speakers noted that resilience is increasingly built through collaboration between API manufacturers and formulators, industry and academia, and across geographies rather than in isolation.
The Founders’ Journey behind the Platform
API Connect is curated by Shikha Agarwal and Shiital Rathod, founders of Ki Eventz, whose journey into building industry platforms began with years of observing conferences from within the ecosystem. Having worked closely with diverse industries and stakeholders, they recognised a gap between how API organisations actually function and how they are often discussed on public platforms.
Their decision to create API Connect was driven by a belief that the industry needed a space for honest, experience-led dialogue, one that acknowledged complexity rather than simplifying it. The founders deliberately positioned the conference away from announcements and projections, focusing instead on execution, learning, and peer exchange.
“The intent was not to create another event, but a forum where professionals could speak openly about what works, what doesn’t, and what needs to evolve,” Rathod noted during the conference. Agarwal added that the response reinforced the relevance of platforms built around substance, trust, and thoughtful curation.
An Industry Willing to Reflect
APIs sit at the intersection of quality, continuity, and credibility. Decisions taken at this stage carry downstream consequences across formulations, regulatory filings, and patient access. API Connect 2026 reflected a maturing industry mindset, one that recognises resilience is built quietly, through systems, people, and disciplined execution.
As the conference concluded, API Connect 2026 – Hyderabad was announced, with dates to be revealed soon, signalling the continuation of a platform designed to support meaningful, industry-led engagement.
In an ecosystem where outcomes are shaped long before a product reaches the patient, API Connect reinforced the value of reflection, collaboration, and partnership in shaping the future of India’s API landscape.
India’s API Ecosystem: Resilience, Innovation & Global Leadership
API Connect centred around a theme that is both timely and critical to the future of global healthcare: “India’s API Ecosystem: Resilience, Innovation & Global Leadership.”
Why This Theme Matters
Over the past few years, Active Pharmaceutical Ingredients have moved from being a behind-the-scenes component of pharmaceuticals to a strategic pillar of global healthcare security. Supply chain disruptions, geopolitical shifts, and heightened regulatory expectations have brought the API ecosystem into sharp global focus.
This theme reflects not only where the industry stands today, but also where it must go next:
- Resilience, proven in times of disruption
- Innovation, essential to remain competitive and sustainable
- Global leadership, a role India is increasingly ready to assume
Conferences like this play a critical role in enabling dialogue, collaboration, and future-focused thinking across the ecosystem.
Resilience: Tested and Proven
India’s API journey is, at its core, a story of resilience.
During recent global disruptions, Indian API manufacturers ensured uninterrupted supply of essential medicines, scaled operations under intense pressure, and reaffirmed India’s credibility as a dependable global partner. This resilience was built on decades of technical expertise, regulatory discipline, and an unwavering commitment to quality.
India did not merely endure disruption; it adapted, responded, and emerged stronger.
Innovation: Defining What Comes Next
Yet, resilience alone is not enough.
The future of India’s API ecosystem will be defined by innovation, not only in chemistry, but in process efficiency, green manufacturing, digitalisation, continuous manufacturing, and advanced analytics.
Indian companies are increasingly advancing toward complex APIs, high-potency products, fermentation-based solutions, and sustainable manufacturing models. Innovation today must balance competitiveness with responsibility, ensuring growth that is scalable, compliant, and environmentally conscious.
Supportive initiatives such as the PLI scheme and bulk drug parks provide a strong foundation. However, real progress will come through deeper industry collaboration, stronger academia–industry partnerships, and continuous skill development.
Global Leadership: From Volume to Value
India is no longer viewed only as a cost-efficient supplier. The global market increasingly looks to India for quality, compliance, reliability, and trust. Regulatory approvals have positioned Indian API manufacturers among the most credible players worldwide.
The next phase of leadership requires a shift from volume to value driven by stronger IP practices, digital adoption, deeper customer engagement, and a sustained focus on quality and sustainability.
“India’s API ecosystem stands at a defining moment. We have the opportunity not just to supply the world, but to shape global healthcare outcomes through resilience, innovation, and leadership. The decisions we make today will define India’s role in the pharmaceutical value chain for decades to come,” concludes Shikha Agarwal, Co-Founder, Ki Eventz.
Ki Eventz is a platform curator focused on creating purposeful industry gatherings that go beyond logistics. With a strong emphasis on connection, collaboration, and long-term impact, Ki Eventz designs conferences and networking platforms that bring together decision-makers, innovators, and enablers to support industry growth and meaningful dialogue.
